ARAKODA (tafenoquine)

SELF ADMINISTRATION

Indications for Prior Authorization: 

  • Indicated for the prophylaxis of malaria in patients aged 18 years and older

Patients must meet the following criteria for the indication(s) above:

  • Patient is 18 years of age or older, AND
  • Patient is traveling to a malaria endemic area, AND
  • Patient has been tested for glucose-6-phosphate dehydrogenase (G6PD) deficiency and does not have G6PD deficiency prior to prescribing Arakoda™, AND
  • Patient will not breastfeed if the infant is found to be G6PD deficient or if G6PD status is unknown, AND
  • Patient does not have a history of psychotic disorders or current psychotic symptoms, AND
  • Patient has tried and failed or had clinically significant adverse effects to a preferred product (e.g. Atovaquone-Proguanil, Chloroquine, Doxycycline, Mefloquine, or Primaquine), unless contraindicated 

Dosing: 

  • Loading Regimen: 200mg (two 100mg tablets) once daily for 3 days
  • Maintenance Regimen: 200mg (two 100mg tablets) once weekly-start 7 days after the last loading regimen dose
  • Terminal Prophylaxis Regimen: 200mg (two 100mg tablets) one-time 7 days after the last maintenance dose

Approval: 

  • One time approval limited to duration of stay in malarious area

Last review date: December 9, 2019

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone